Novo Nordisk to cut US list prices for several insulin products by up to 75 percent next year Ruchika Sharma15 March 2023 3:15 PM ISTThe Danish drugmaker will reduce the list price of its NovoLog insulin by 75%, and for Novolin and Levemir by 65%.
Eli Lilly-Boehringer's Jardiance for children with type 2 diabetes accepted by USFDA Ruchika Sharma10 March 2023 12:23 PM ISTIndianapolis: Boehringer Ingelheim and Eli Lilly and Company have announced that the U.S. Food and Drug Administration (FDA) has accepted a...
USFDA broadens indication for Eli Lilly's Verzenio in HR+, HER2-, Node-Positive, High Risk Early Breast Cancer Ruchika Sharma5 March 2023 4:30 PM ISTVerzenio (abemaciclib) is a targeted treatment known as a CDK4/6 inhibitor.
Eli Lilly to cut insulin prices by 70 percent Ruchika Sharma2 March 2023 2:15 PM ISTThe company will lower the price of Humalog, its most commonly prescribed insulin, and Humulin, by 70 percent starting in the fourth quarter of this...
Eli Lilly Gets CDSCO Panel Nod To Import, Market Lasmiditan for acute treatment of migraine Dr. Divya Colin25 Feb 2023 6:00 PM ISTNew Delhi: Citing that the global clinical trial data demonstrate the efficacy and safety of Lasmiditan for the acute treatment of migraine with and...
Anticancer drug: CDSCO panel seeks data for Eli Lilly Selpercatinib Dr. Nandita Mohan22 Feb 2023 5:30 PM ISTIn response to the drug major Eli Lilly's proposal to waive off Phase IV clinical trial in the country for the Selpercatinib 40 & 80mg capsules,...
Health Bulletin 22/February/2023 Dr. Nandita Mohan22 Feb 2023 4:19 PM ISTHere are the top health stories for the day:5 emergency seats at MGM Indore approved by NMCThe Medical Assessment and Rating Board (MARB) of National...
Eli Lilly diabetes drug Mounjaro back to shelf after two month shortage Ruchika Sharma22 Feb 2023 1:30 PM ISTAmerica: Eli Lilly & Co said on Tuesday all doses of its new diabetes drug Mounjaro were now available with wholesalers having inventory on...
CDSCO panel seeks data for Eli Lilly's anticancer drug selpercatinib Dr. Divya Colin21 Feb 2023 6:00 PM ISTNew Delhi: In response to the drug major Eli Lilly's proposal to waive off Phase IV clinical trial in the country for the Selpercatinib 40 & 80mg...
Eli Lilly gets CDSCO panel nod to study anticancer drug Imlunestrant Dr. Divya Colin9 Feb 2023 6:00 PM ISTNew Delhi: The drug major, Eli Lilly has got approval from the Subject Expert Committee (SEC) functional under the Central Standard Drug Control...
Eli Lilly oncology unit gets USFDA nod for Jaypirca to treat mantle cell lymphoma Ruchika Sharma29 Jan 2023 4:15 PM ISTMCL is a rare blood cancer and a form of non-Hodgkin lymphoma.
Eli Lilly gets CDCSO panel nod to import, market Galcanezumab Dr. Divya Colin25 Jan 2023 5:44 PM ISTNew Delhi: Drug major, Eli Lilly has got a go ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
